Search

MacroGenics Inc

Suletud

SektorTervishoid

4.66 -2.31

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

4.55

Max

5.03

Põhinäitajad

By Trading Economics

Sissetulek

-23M

-37M

Müük

-20M

21M

Aktsiakasum

-0.58

Kasumimarginaal

-177.011

Töötajad

293

EBITDA

-15M

-30M

Soovitused

By TipRanks

Soovitused

Osta

12 kuu keskmine prognoos

+32.43% upside

Dividendid

By Acuity

Järgmine tulemuste avaldamine

12. aug 2026

Turustatistika

By TradingEconomics

Turukapital

104M

291M

Eelmine avamishind

6.97

Eelmine sulgemishind

4.66

Uudiste sentiment

By Acuity

41%

59%

123 / 342 Pingereas Healthcare

MacroGenics Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

24. juuni 2026, 23:56 UTC

News
Correlated Moves

Ethereum is trading lower during Wednesday's session, reflecting broader market trends as Bitcoin also declines. The cryptocurrency remains below its 20-day moving average.

24. juuni 2026, 23:52 UTC

News
Correlated Moves
Social Media

Applied Materials shares rose in after-market trading, boosted by strong earnings from Micron Technology and positive sentiment in the semiconductor sector.

24. juuni 2026, 23:52 UTC

News
Correlated Moves

Lam Research Corp shares rise in after-market trading, driven by positive sentiment from Micron Technology's strong results and broader semiconductor sector gains.

24. juuni 2026, 23:41 UTC

News

The iShares Core U.S. Aggregate Bond ETF is trading lower in after-market hours, following a session marked by declines and mixed global market dynamics.

24. juuni 2026, 23:41 UTC

News
Correlated Moves

Alphabet Inc. shares are lower in after-market hours, down $1.13 to about $345.00, amid a broader decline in the Interactive Media & Services sector.

24. juuni 2026, 23:41 UTC

Event
News

Trip.com Group Ltd's stock is lower in after-market trading following a first-quarter net income decline and reduced second-quarter revenue guidance.

24. juuni 2026, 23:41 UTC

ETF Constituents
News
Social Media

Invesco QQQ Trust Series I rises in after-market trading, boosted by strong Q3 earnings from Micron Technologies and positive sentiment from tech sector recovery.

24. juuni 2026, 23:41 UTC

News
Correlated Moves

Western Digital shares rose sharply in after-hours trading following strong Q3 results from Micron Technology, which beat earnings and revenue expectations.

24. juuni 2026, 23:41 UTC

Correlated Moves
News

iShares Silver Trust is trading higher in after-market hours, reflecting recovery after recent declines despite slight decreases in gold prices.

24. juuni 2026, 23:41 UTC

Correlated Moves
News

SPDR Gold Shares advance in after-market trading despite lower gold prices and a slight decline in silver. U.S. stocks show generally higher performance.

24. juuni 2026, 23:41 UTC

Correlated Moves
News
Social Media

Qualcomm shares rose after Investor Day, doubling fiscal 2029 non-handset revenue targets to $40 billion and announcing a partnership with Meta Platforms for data center CPUs.

24. juuni 2026, 23:41 UTC

News

Comcast shares are higher after reports of its subsidiary Sky acquiring ITV's Broadcast unit for about £1.6 billion, pending legal review.

24. juuni 2026, 23:36 UTC

News

Gilead Sciences' Trodelvy receives FDA approval for first-line treatment of triple-negative breast cancer, boosting shares in after-market hours.

24. juuni 2026, 23:32 UTC

News
Event
Social Media

Micron Technology reported record third-quarter revenue of $41.46 billion and strong fourth-quarter guidance, driving shares higher in after-market trading.

24. juuni 2026, 23:31 UTC

News
Social Media

United States Oil Fund LP is trading higher in after-market hours following a larger-than-expected drop in U.S. crude oil inventories for the week.

24. juuni 2026, 23:11 UTC

Correlated Moves
News
Social Media

Meta shares rise in after-market trading following a strategic partnership with Qualcomm and government discussions on AI oversight.

24. juuni 2026, 23:06 UTC

News
Social Media

Tesla Inc shares are higher in after-market trading, supported by a multi-year agreement with NatPower for battery energy storage systems in Europe.

24. juuni 2026, 23:06 UTC

Correlated Moves
News

The iShares 7-10 Year Treasury Bond ETF is trading higher in after-market hours, reflecting routine movement near its one-month trading range.

24. juuni 2026, 23:06 UTC

News
Correlated Moves
ETF Constituents

SPDR Dow Jones Industrial Average ETF Trust rises in after-market trading, aided by strong earnings from Micron Technologies and lower oil prices this week.

24. juuni 2026, 23:05 UTC

News
Correlated Moves

The Vanguard Total Bond Market ETF is higher in after-market hours, reflecting broader market recovery amid easing concerns over U.S.-Iran negotiations affecting energy supply.

24. juuni 2026, 23:02 UTC

News
ETF Constituents

The Vanguard Growth ETF is gaining in after-market trading, supported by strong performances from AMD and KLA Corporation. Oil prices have declined below $80 per barrel.

24. juuni 2026, 23:02 UTC

News
Correlated Moves

The iShares 20+ Year Treasury Bond ETF is higher in after-market trading, buoyed by U.S. Bancorp's dividend increase and positive sentiment in fixed-income securities.

24. juuni 2026, 23:02 UTC

News
ETF Constituents
Macro News

Vanguard Information Technology ETF gains after-hours, supported by Micron Technology's record earnings and strong performance from top holdings.

24. juuni 2026, 23:01 UTC

News

Charter Communications Inc. gains in after-market trading, supported by positive sentiment from the Federal Reserve's stress test results and strong mobile segment growth.

24. juuni 2026, 22:51 UTC

News

Booking Holdings Inc may benefit from falling oil prices, with WTI crude below $70 and Brent at $74, potentially boosting travel demand. Shares are roughly flat in after-market trading.

24. juuni 2026, 20:07 UTC

News

Business confidence in Germany rose, lifting the EUR/ZAR higher during Wednesday's session. The Ifo index increased to 85.6 points, surpassing expectations.

24. juuni 2026, 20:06 UTC

News
Correlated Moves

The US Dollar Index has risen, supporting higher trading in USD/DKK amid a broader trend of strength in the U.S. dollar.

24. juuni 2026, 20:06 UTC

Macro Event
News
Correlated Moves

The U.S. current account deficit widened to $226.8 billion, influencing notable volatility in the USD/CZK exchange rate, which is higher since Tuesday's close.

24. juuni 2026, 20:06 UTC

News
Correlated Moves

The US dollar's strength drives USD/SGD higher, reflecting a flight to safety amid economic and geopolitical concerns. The pair remains near its one-month trading range.

24. juuni 2026, 20:06 UTC

News
Correlated Moves

USD/SEK is trading higher as the US Dollar Index strengthens amid a flight to safety, recovering from a midday dip while above its 20-day moving average.

Võrdlus sarnastega

Hinnamuutus

MacroGenics Inc Prognoos

Hinnasiht

By TipRanks

32.43% tõus

12 kuu keskmine prognoos

Keskmine 6.33 USD  32.43%

Kõrge 9 USD

Madal 4 USD

Põhineb 4 Wall Streeti analüütiku instrumendi MacroGenics Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

4 ratings

2

Osta

2

Hoia

0

Müü

Sentiment

By Acuity

123 / 342 Pingereas Tervishoid

Uudiste sentiment

Languse märgid

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Üle keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest MacroGenics Inc

MacroGenics, Inc., a biopharmaceutical company, develops, manufactures, and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients with metastatic HER2-positive breast cancer who have received two or more prior anti-HER2 regimens. The company's pipeline of immuno-oncology product candidates includes MGC018, an antibody drug conjugate (ADC), which targets solid tumors expressing B7-H3; Enoblituzumab, a monoclonal antibody that targets B7-H3; and MGD024, an investigational bispecific CD123 × CD3 DART molecule to minimize cytokine-release syndrome for patients with hematologic malignancies. In addition, it develops Lorigerlimab, a monoclonal antibody that targets the immune checkpoints PD-1 and cytotoxic T-lymphocyte-associated protein 4; Tebotelimab, an investigational tetravalent DART molecule for PD-1 and lymphocyte-activation gene 3; Retifanlimab, a humanized monoclonal antibody targeting programmed death receptor-1; and IMGC936, an ADC that targets ADAM9, a cell surface protein over-expressed in various solid tumor types. Further, the company develops MGD014 and MGD020, a DART molecule to target the envelope protein of human immunodeficiency virus infected cells and CD3 on T cells; Teplizumab for the treatment of type 1 diabetes; and PRV-3279, a CD32B × CD79B DART molecule for the treatment of autoimmune indications. It has collaborations with Incyte Corporation; Zai Lab Limited; I-Mab Biopharma; and Janssen Biotech, Inc. The company was incorporated in 2000 and is headquartered in Rockville, Maryland.
help-icon Live chat